Valora Therapeutics Raises $30 Million Seed Financing from Top Investors to Transform Immunotherapy with a Novel Glyco-immune Checkpoint Platform
November 20, 2024 07:00 AM Eastern Standard Time SAN DIEGO–(BUSINESS WIRE)–Valora Therapeutics Inc. (“Valora”), a biotechnology company pioneering a novel approach to immunotherapy, today announced the successful closing of its seed funding round. The investment…